Literature DB >> 17029966

Autoimmunity versus tolerance: can dying cells tip the balance?

Irene C B Viorritto1, Nikolay P Nikolov, Richard M Siegel.   

Abstract

Apoptosis is a physiological process of self-destruction for cells that are damaged or programmed to die. Apoptosis occurs through a series of regulated events that allow cellular debris to be contained and efficiently phagocytosed without initiating a proinflammatory immune response. Recent data have linked physiological apoptosis and the uptake of apoptotic cells by macrophages and some subsets of dendritic cells to the maintenance of peripheral immune tolerance. However, when cells die through necrosis, spilling their intracellular contents, or are infected with various pathogens, activation of antigen-presenting cells and induction of an immune response can occur. Receptors for extrinsic pathogen-associated structures, such as membrane bound Toll-like receptors (TLRs) or intracellular Nod-like receptors (NLRs) can also respond to cross-reactive host molecules from dying cells and may focus autoimmune responses onto these antigens. Several autoimmune disorders have been linked to defects in the apoptotic process. Defective apoptosis of immune cells leads to autoimmunity, as in autoimmune lymphoproliferative syndrome (ALPS) associated with mutations in the death receptor Fas. Defective clearance of apoptotic cell debris can also lead to autoantibody production. We will discuss how cell death and apoptotic cell clearance may affect the finely tuned balance between peripheral immune tolerance and autoimmunity.

Entities:  

Mesh:

Year:  2006        PMID: 17029966      PMCID: PMC1805813          DOI: 10.1016/j.clim.2006.07.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  69 in total

1.  Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family.

Authors:  Christoph Heiring; Björn Dahlbäck; Yves A Muller
Journal:  J Biol Chem       Date:  2003-11-17       Impact factor: 5.157

2.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.

Authors:  J Savill; N Hogg; Y Ren; C Haslett
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 3.  Natural serum IgM maintains immunological homeostasis and prevents autoimmunity.

Authors:  Jessica J Manson; Claudia Mauri; Michael R Ehrenstein
Journal:  Springer Semin Immunopathol       Date:  2004-12-21

4.  Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function.

Authors:  Roman Spörri; Caetano Reis e Sousa
Journal:  Nat Immunol       Date:  2005-01-16       Impact factor: 25.606

5.  Toll-like receptor 3 promotes cross-priming to virus-infected cells.

Authors:  Oliver Schulz; Sandra S Diebold; Margaret Chen; Tanja I Näslund; Martijn A Nolte; Lena Alexopoulou; Yasu-Taka Azuma; Richard A Flavell; Peter Liljeström; Caetano Reis e Sousa
Journal:  Nature       Date:  2005-02-13       Impact factor: 49.962

Review 6.  Approaching the asymptote? Evolution and revolution in immunology.

Authors:  C A Janeway
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

7.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.

Authors:  R Medzhitov; P Preston-Hurlburt; C A Janeway
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

8.  Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice.

Authors:  Jerrold M Ward; Nikolay P Nikolov; Jolynne R Tschetter; Jeffrey B Kopp; Frank J Gonzalez; Shioko Kimura; Richard M Siegel
Journal:  Toxicol Pathol       Date:  2004 Nov-Dec       Impact factor: 1.902

9.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

10.  Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.

Authors:  Sean R Christensen; Michael Kashgarian; Lena Alexopoulou; Richard A Flavell; Shizuo Akira; Mark J Shlomchik
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

View more
  26 in total

Review 1.  Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.

Authors:  Madhu Ramaswamy; Min Deng; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

2.  Indirect involvement of allergen-captured mast cells in antigen presentation.

Authors:  Taku Kambayashi; Jan D Baranski; Rebecca G Baker; Tao Zou; Eric J Allenspach; Jonathan E Shoag; Peter L Jones; Gary A Koretzky
Journal:  Blood       Date:  2007-11-21       Impact factor: 22.113

3.  Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.

Authors:  Daniel R Getts; Danielle M Turley; Cassandra E Smith; Christopher T Harp; Derrick McCarthy; Emma M Feeney; Meghann Teague Getts; Aaron J Martin; Xunrong Luo; Rachael L Terry; Nicholas J C King; Stephen D Miller
Journal:  J Immunol       Date:  2011-08-05       Impact factor: 5.422

Review 4.  Sensors of the innate immune system: their link to rheumatic diseases.

Authors:  Argyrios N Theofilopoulos; Rosana Gonzalez-Quintial; Brian R Lawson; Yi T Koh; Michael E Stern; Dwight H Kono; Bruce Beutler; Roberto Baccala
Journal:  Nat Rev Rheumatol       Date:  2010-02-09       Impact factor: 20.543

Review 5.  Liquid biopsy: monitoring cancer-genetics in the blood.

Authors:  Emily Crowley; Federica Di Nicolantonio; Fotios Loupakis; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2013-07-09       Impact factor: 66.675

Review 6.  Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.

Authors:  Kun Nie; Yujie Jia; Xuezhu Zhang
Journal:  Tumour Biol       Date:  2014-10-29

Review 7.  Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.

Authors:  Kelan A Hlavaty; Xunrong Luo; Lonnie D Shea; Stephen D Miller
Journal:  Clin Immunol       Date:  2015-03-21       Impact factor: 3.969

Review 8.  Circulating and stool nucleic acid analysis for colorectal cancer diagnosis.

Authors:  Giulia De Maio; Claudia Rengucci; Wainer Zoli; Daniele Calistri
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

9.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.

Authors:  Daniel R Getts; Aaron J Martin; Derrick P McCarthy; Rachael L Terry; Zoe N Hunter; Woon Teck Yap; Meghann Teague Getts; Michael Pleiss; Xunrong Luo; Nicholas J C King; Lonnie D Shea; Stephen D Miller
Journal:  Nat Biotechnol       Date:  2012-11-18       Impact factor: 54.908

10.  Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

Authors:  Balakrishnan Mahesh; Hon-Sing Leong; Ann McCormack; Padmini Sarathchandra; Angela Holder; Marlene L Rose
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.